Bonesupport Holding stock

BONEX · Nasdaq Stockholm · SEK

Compare Bonesupport Holding
kr 324.80Change from previous close: +0.31%Absolute change: +kr 1.00

Close · November 20, 2026

Price history

+63.87% over the period

1 year: from kr 198.20 (November 20, 2025) to kr 324.80 (November 20, 2026), +63.87%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026kr 324.80
October 30, 2026kr 325.00
September 30, 2026kr 227.60
August 31, 2026kr 218.60
July 31, 2026kr 220.20
June 30, 2026kr 211.40
May 29, 2026kr 229.80
April 30, 2026kr 220.60
March 31, 2026kr 194.90
February 27, 2026kr 202.40
January 30, 2026kr 185.00
December 30, 2025kr 188.00
November 28, 2025kr 201.80
November 20, 2025kr 198.20

At a glance

  • The company

    Develops and commercializes injectable bio-ceramic bone graft substitutes for bone repair and infection prevention

  • Latest results

    Quarter to September 30, 2026 · EPS kr 1.40 (estimate kr 1.26)

TickerLandia's take on Bonesupport Holding

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowkr 165.00
52-wk highkr 340.20

−4.53% from the 52-week high

Analysts · 5 analysts

Average targetkr 374.67+15.35% vs. price

Buy 5 · Hold 0 · Sell 0

TickerLandia Fingerprint: Bonesupport Holding

Compared with similar companies: very strong momentum, very low earnings stability, and very high growth.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Bonesupport Holding is pricier than similar companies

Bonesupport Holding's P/E (trailing 12 months): 78.1, +211% against the median of a group of 9 similar companies (25.1).

Compared with 9 similar companies

Bonesupport Holding's metrics compared with similar companies
MetricBonesupport HoldingPosition in the groupBand
P/E (trailing 12 months)78.1High
Forward P/E72.9High
Operating margin25.5%High
ROE29.7%High
Debt/equity0.01Low

Grey band: the middle half of the group; tick: the median; dot: Bonesupport Holding. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

kr 408.83M

Latest quarter · Q3 2026

Net income

kr 92.36M

Latest quarter · Q3 2026

Quarterly net margin

22.6%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
kr 20.72B
P/E
78.1
EPS
kr 4.08
Volume
183.24K
Daily trading
€9.14M
Dividend yield
0.00%

How Bonesupport Holding is changing

All results
  • Revenue grew 45.4% a year on average over the last 5 years

  • Operating margin rose from −20.6% to 23.6%

  • Less cash than profit: free cash flow equal to 51% of net income

Returns

Bonesupport Holding returns

kr 1,000 invested in Bonesupport Holding 5 years ago, on November 22, 2021, would be worth kr 8,458 today: +745.83% in total, +53.35% per year. This is the price return only: dividends are excluded.

PeriodBonesupport Holdingkr 1,000 becomes
1 month+27.87%kr 1,279
6 months+25.60%kr 1,256
Year to date+72.77%kr 1,728
1 year+63.87%kr 1,639
3 years+98.05%kr 1,980
5 years+745.83%kr 8,458

Price only, without dividends. Calculate your investment

The chart in detail

Bonesupport Holding: technical analysis

Bonesupport Holding is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 18.8% below its all-time closing high (kr 400.20, January 3, 2025).

Trend
Upward
RSI (14 sessions)
63
Between 30 and 70
vs 200-session average
+41.08%

Active signals

  • The price is moving in an unusually narrow range compared with the last year.

Support and resistance

Price areas where Bonesupport Holding has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last pricekr 324.80
  3. Supportkr 245.40−24.45%2 touches, last on October 21, 2026
  4. Supportkr 234.37−27.84%7 touches, last on September 30, 2026
  5. Supportkr 215.30−33.71%4 touches, last on October 8, 2026

Volatility and risk

Volatility (60 sessions, annualised)
57.8%
Largest fall in the last year
−25.95%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Bonesupport Holding: seasonality

Average monthly price change over 10 years

−0.3%Jan−0.9%Feb−4.0%Mar+7.5%Apr+7.2%May+8.0%Jun+10.3%Jul−2.4%Aug+5.0%Sep+3.1%Oct+3.7%Nov+3.1%Dec

Over the last 10 years, the strongest month for Bonesupport Holding has been July: +10.28% on average, positive in 9 years out of 10. The weakest has been March: −3.96% on average, positive in 4 years out of 9. November, the current month, has been positive in 5 years out of 9 (+3.66% on average).

Show chart data
MonthAverageMedianPositive years
January−0.32%−3.59%3 of 9
February−0.91%+0.83%5 of 9
March−3.96%−3.71%4 of 9
April+7.53%+9.67%6 of 9
May+7.18%+7.35%7 of 9
June+7.95%+8.04%7 of 9
July+10.28%+9.76%9 of 10
August−2.37%−0.79%4 of 10
September+4.96%+1.65%6 of 10
October+3.08%+1.19%5 of 10
November+3.66%+1.34%5 of 9
December+3.06%+5.57%5 of 9

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Bonesupport Holding and its competitors

CERAMENT is the name customers know Bonesupport by: an injectable bio-ceramic bone graft substitute that remodels into host bone. The range includes CERAMENT G and CERAMENT V, which elute gentamicin or vancomycin during the first 30 days of bone healing and are used to treat and prevent bone infection, and CERAMENT Bead Tray, a local delivery option for surgeons treating osseous defects and dead space. The company sells these orthobiologics products in the United States, Europe and other international markets.

Headquarters
Lund, Sweden
Employees
174
Founded
1999
Chief executive
Torbjorn Skold
Bonesupport Holding and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Bonesupport HoldingBONEX$2.03B25.5%78.1+25.60%
AddLifeALIF.B$2.11B8.9%33.5+17.73%
OttobockOBCK$2.68B18.7%19.0−31.33%
Carl Zeiss MeditecAFX$3.07B7.2%23.3+24.32%
GerresheimerGXI$1.19B1.6%—+21.95%
Tecan GroupTECN$3.58B4.9%—+64.44%

Same industry or related industries, similar size. Compare Bonesupport Holding with its competitors · Full profile